Filamentous bacteriophage: biology, phage display and nanotechnology applications J Rakonjac, NJ Bennett, J Spagnuolo, D Gagic, M Russel Current issues in molecular biology 13 (2), 51-76, 2011 | 489 | 2011 |
Modulation of bacterial metabolism by the microenvironment controls MAIT cell stimulation M Schmaler, A Colone, J Spagnuolo, M Zimmermann, M Lepore, ... Mucosal immunology 11 (4), 1060-1070, 2018 | 72 | 2018 |
Identification of the gate regions in the primary structure of the secretin pIV J Spagnuolo, N Opalka, WX Wen, D Gagic, E Chabaud, P Bellini, ... Molecular microbiology 76 (1), 133-150, 2010 | 57 | 2010 |
MR1-restricted T cells are unprecedented cancer fighters A Vacchini, A Chancellor, J Spagnuolo, L Mori, G De Libero Frontiers in immunology 11, 751, 2020 | 38 | 2020 |
Inter- and intra-molecular interactions of Arabidopsis thaliana DELLA protein RGL1 DJ Sheerin, J Buchanan, C Kirk, D Harvey, X Sun, J Spagnuolo, S Li, ... Biochemical Journal 435 (3), 629-639, 2011 | 28 | 2011 |
In vitro synergy between sodium deoxycholate and furazolidone against enterobacteria VVH Le, C Olivera, J Spagnuolo, IG Davies, J Rakonjac BMC microbiology 20, 1-11, 2020 | 16 | 2020 |
Interferon lambda 4 can directly activate human CD19+ B cells and CD8+ T cells M Coto-Llerena, M Lepore, J Spagnuolo, D Di Blasi, D Calabrese, ... Life science alliance 4 (1), 2021 | 8 | 2021 |
Immunophenotypic characterization of TCR γδ T cells and MAIT cells in HIV-infected individuals developing Hodgkin’s lymphoma CKS Muller, J Spagnuolo, A Audigé, A Chancellor, D Russenberger, ... Infectious Agents and Cancer 16, 1-15, 2021 | 5 | 2021 |
Revealing viral and cellular dynamics of HIV-1 at the single-cell level during early treatment periods F Otte, Y Zhang, J Spagnuolo, A Thielen, M Däumer, C Wiethe, ... Cell Reports Methods 3 (6), 2023 | 3 | 2023 |
Nucleobase adducts bind MR1 and stimulate MR1-restricted T cells A Vacchini, A Chancellor, Q Yang, R Colombo, J Spagnuolo, G Berloffa, ... Science Immunology 9 (95), eadn0126, 2024 | 2 | 2024 |
Nucleobase adduct-containing metabolites are MR1 ligands that stimulate self-reactive MR1T cells A Vacchini, Q Yang, A Chancellor, J Spagnuolo, D Joss, O Øyås, ... BioRxiv, 2022.08. 26.505411, 2022 | 2 | 2022 |
Mr1 ligands and pharmaceutical compositions for immunomodulation G De Libero, L Mori, A Vacchini, A Chancellor, J Spagnuolo, Y Qinmei US Patent App. 17/793,419, 2023 | 1 | 2023 |
Extracytoplasmic stress responses induced by a model secretin: a dissertation presented in partial fulfilment of the requirements for the degree of Doctor of Philosophy in … J Spagnuolo Massey University, 2015 | 1 | 2015 |
Defining the gate domain of the filamentous phage secretin pIV J Spagnuolo Massey University, 2010 | 1 | 2010 |
Surface protein and functional analyses identify CD4+CD39+ TCR αβ+ and activated TCR Vδ1+ cells with distinct pro-inflammatory functions in Crohn’s disease … J Devan, V Nosi, J Spagnuolo, A Chancellor, A Beshirova, JP Loureiro, ... Clinical and Experimental Immunology 215 (1), 79-93, 2024 | | 2024 |
Antibacterial combinations J Rakonjac, C Olivera, R Weerasinghe, J Spagnuolo US Patent App. 17/274,115, 2021 | | 2021 |
MR1T cells recognising self-antigens are adaptive-like T cells A Vacchini, A Chancellor, J Spagnuolo, Q Yang, L Mori, G De Libero SWISS MEDICAL WEEKLY, 2S-2S, 2019 | | 2019 |
In vitro synergy between Sodium Deoxycholate and Furazolidone against Enterobacteria via Inhibition of Multidrug Efflux Pumps VVH Le, C Olivera, J Spagnuolo, I Davies, J Rakonjac bioRxiv, 518050, 2019 | | 2019 |
Identification of the gate regions in the primary structure of the secretin pIVmmi_7085 J Spagnuolo, N Opalka, WX Wen, D Gagic, E Chabaud, P Bellini, ... | | 2010 |